Open original FDA record ↗Recall record
- FDA identifier
- Z-0714-2024
- Company in FDA record
- Ambu Inc.
- FDA classification date
- Jan 11, 2024
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Instructions for Use have been updated to add the following warning: Use only M4 screws with the length of 14 16 mm when mounting Ambu aView 2 Advance on a VESA interface. Using longer screw lengths will penetrate the lithium-ion battery and result in a fire hazard and battery leakage which can cause severe burns, smoke inhalation and skin irritation. Using shorter screw lengths could result in unsecure device fastening.
Source facts
- Action
- On December 5, 2023, the firm began notifying their customers via Urgent Field Safety Notice (Correction) letters. Customers were provided with an insert of Instructions for Use to include with their Instructions for Use booklet that highlights the new warning. Should you have additional questions, please contact Sanjay Parikh (sap@ambu.com) or Tammy Feyerherm (tfey@ambu.com).
- Initiated
- 2023-12-05
- Root cause
- Device Design
- Distribution
- Domestic distribution nationwide.
- Recall number
- Z-0714-2024
- Recall status
- Open, Classified
- CDRH record ID
- 204948
- FDA classified
- 2024-01-11
- Recall event number
- 93599